Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.

Della Pepa C, Tonini G, Santini D, Losito S, Pisano C, Di Napoli M, Cecere SC, Gargiulo P, Pignata S.

Cancer Treat Rev. 2015 Feb;41(2):136-43. doi: 10.1016/j.ctrv.2014.12.003. Review.

PMID:
25573350
2.

Ovarian cancer standard of care: are there real alternatives?

Della Pepa C, Tonini G, Pisano C, Di Napoli M, Cecere SC, Tambaro R, Facchini G, Pignata S.

Chin J Cancer. 2015 Jan;34(1):17-27. doi: 10.5732/cjc.014.10274. Review.

3.

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer.

Della Pepa C, Banerjee S.

Onco Targets Ther. 2014 Jun 19;7:1025-32. doi: 10.2147/OTT.S40527. Review. Erratum in: Onco Targets Ther. 2014;7:1473.

4.

Microbe-host interactions: structure and role of Gram-negative bacterial porins.

Galdiero S, Falanga A, Cantisani M, Tarallo R, Della Pepa ME, D'Oriano V, Galdiero M.

Curr Protein Pept Sci. 2012 Dec;13(8):843-54. Review.

Supplemental Content

Loading ...
Support Center